Rocket Lab’s Summer of Reckoning: A 35% Monthly Sell-Off, a Neutral Analyst, and the Neutron Deadline
Published on 07/18/2026 at 04:22 | Redaktion boerse-global.de
The paradox of Rocket Lab right now is that the company is executing well – a successful hot-fire test of the Neutron’s vacuum engine, record Electron launches, and an $8 billion acquisition that expands its reach beyond launch services – yet its stock is in freefall. Shares ended the week at $69.80, a modest 3.64% gain for the session, but that did little to mask a brutal stretch. Over the past month, the equity has cratered 35.36%; over the trailing 30 days, the decline touches 36.77%. The year-to-date performance stands at a meager 0.06%, effectively erasing every gain from the first half of 2026.
The primary catalyst for the sell-off is not one event but a confluence of pressures. The June initial public offering of SpaceX removed the scarcity premium that Rocket Lab had long enjoyed as the only publicly traded pure-play in orbital launch. When SpaceX itself slipped below its IPO price, a sector-wide valuation reset followed. Rocket Lab’s stock now sits 53.77% below its 52-week high, with a market capitalization of €41.93 billion.
Then came Piper Sandler. The bank initiated coverage with a neutral rating and an $83 price target, citing concerns about the planned $8 billion acquisition of Iridium Communications. That deal, announced on June 29, 2026, aims to transform Rocket Lab from a rocket builder into a vertically integrated space infrastructure company that owns satellites and spectrum. But Piper Sandler flagged integration and dilution risks that investors are still weighing.
The Neutron rocket program adds another layer of uncertainty. First flight remains targeted for the fourth quarter of 2026, and the company hit a technical milestone on July 13 with a full-duration hot-fire test of the vacuum-optimised AVac engine. Yet the timeline has already suffered a setback: in January, a fuel-tank test accident disrupted the schedule. With little public detail on hardware progress since then, the market is growing impatient. Five firm commercial missions are booked ahead of the first flight, but until the hardware is proven, the risk of further delays hangs over the story.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The technical picture is deeply oversold. The 14-day relative strength index stands at 32.5 in one reading and 30.9 in another – both firmly in oversold territory. The stock trades 10.69% below its 200-day moving average of $78.16 and a staggering 35.02% below its 50-day average of $107.41. The last seven trading sessions alone delivered a cumulative decline of 13.87%. While oversold conditions often precede a bounce, they are no guarantee. Friday’s modest gain looks more like a pause than a reversal.
Against this, the bull case rests on fundamentals that remain intact. Rocket Lab reported a record backlog of $2.2 billion at the end of the first quarter, backed by more than $2 billion in available liquidity. The Electron rocket delivered a record first half in launch activity, generating stable cash flow. The broader analyst community remains constructive: 81% of 16 analysts rate the stock a Buy or Strong Buy, with a consensus price target of $117 – implying substantial upside from current levels.
The bear case, however, is equally persuasive on valuation grounds. The stock trades at a price-to-sales ratio of 72.2, compared to 3.3 for the S&P 500. That premium can compress further if Neutron stumbles again or if the Iridium integration proves more expensive than anticipated. Rocket Lab’s volatility profile magnifies the risk: the stock lost 83% from its peak during the 2022 inflation shock, and the current 30-day annualized volatility has surged to 97%. Options markets are pricing in continued large swings.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
The deciding factors are binary. A smooth execution on Neutron’s qualification tests in the fourth quarter and a clean path to the Iridium close would validate the bull thesis. Another delay on the rocket or unexpected costs in the telecom deal would reinforce the bearish view that the valuation has further to shrink. Investors will get their next official update when Rocket Lab reports second-quarter earnings, expected in early August 2026 – a date that still requires confirmation from the company. Until then, the stock is caught between an oversold technical reading and a story that has yet to deliver its biggest chapters.
Ad
Rocket Lab USA Stock: New Analysis - 18 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
